[1]
“Evaluation of the safety and effectiveness of the combination of gemcitabine monochemotherapy and high-intensity focused ultrasound therapy in the treatment of patients with adenogenic pancreatic cancer”, Вопр. онкол., vol. 68, no. 6, pp. 780–785, Dec. 2022, doi: 10.37469/0507-3758-2022-68-6-780-785.